Chiarenza, Annalisa

Functional and clinical relevance of VLA-4 (CD49d/CD29) in ibrutinib-treated chronic lymphocytic leukemia

Tissino, E., Benedetti, D., Herman, S. E. M., ten Hacken, E., Ahn, I. E., Chaffee, K. G., Rossi, F. M., Dal Bo, M., Bulian, P., Bomben, R., et al. (2018) · Journal of Experimental Medicine

Chronic Lymphocytic Leukemia ResearchCell Adhesion Molecules Research

Cited by 92

CD49d promotes disease progression in chronic lymphocytic leukemia: new insights from CD49d bimodal expression

Tissino, E., Pozzo, F., Benedetti, D., Caldana, C., Bittolo, T., Rossi, F. M., Bomben, R., Nanni, P., Chivilò, H., Cattarossi, I., et al. (2020) · Blood

Chronic Lymphocytic Leukemia ResearchLymphoma Diagnosis and Treatment

Cited by 63

Chronic lymphocytic leukemia cells with mutated nfkbie are positively selected by microenvironmental signals and display reduced sensitivity to ibrutinib treatment

Bonato, A., Bomben, R., Chakraborty, S., Felician, G., Martines, C., Zucchetto, A., Chiarenza, A., Del Poeta, G., Marasca, R., Tafuri, A., et al. (2021) · Blood

Chronic Lymphocytic Leukemia ResearchLymphoma Diagnosis and Treatment

Cited by 3